Mortality News and Research

RSS

Study shows appropriate use of CRRT improves AKI patient outcomes

A study appearing today in the New England Journal of Medicine adds to the growing body of evidence supporting continuous renal replacement therapy (CRRT) as the therapy of choice for treatment of acute kidney injury (AKI) patients in the intensive care unit (ICU).

23 Oct 2009

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

Aeolus Pharmaceuticals, Inc. announced today that recent experiments in preclinical models conducted by the National Institutes of Health’s (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasure Development program have shown that AEOL 10150 can effectively increase regeneration of gastro-intestinal (GI) stem cells, reduce the severity and duration of diarrhea and improve survival when administered at 24 hours after doses of total-body irradiation that produce the lethal GI syndrome.

23 Oct 2009

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial. This is a two phase 42-patient 'feasibility' clinical trial using the company's BMAC System to concentrate autologous bone marrow cells to treat patients with congestive heart failure undergoing treatment with coronary artery bypass grafting (CABG) Surgery.

22 Oct 2009

Study explores aldosterone antagonist usage among US patients hospitalised with heart failure

A study published today in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated.

22 Oct 2009

Experts discuss methods to prevent catheter-associated urinary tract infections

It's a statistic that almost every healthcare facility knows: 40 percent of all healthcare-acquired infections are urinary tract infections (UTI). Since catheters -- the most common source of these infections -- are used on over four million hospital patients a year, the chances of a patient getting a UTI are pretty high. In fact, the daily risk for patients acquiring a urinary infection is as high as seven percent when indwelling urethral catheters remain in their original position.

22 Oct 2009

New results from ADVANCE provide important insights to reduce diabetes complications

New results from ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation), the largest clinical trial ever performed in patients with type 2 diabetes worldwide, provide important insights into the therapeutic strategy to adopt for efficient and safe blood glucose control aimed at the reduction of severe diabetes complications.

21 Oct 2009

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

21 Oct 2009

New tools needed to identify men and women at risk for the most aggressive cancers

Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."

21 Oct 2009

Eclipsys' 2009 Circle of Excellence Award winners announced

Eclipsys Corporation®, The Outcomes Company®, today announced the winners of its 2009 Circle of Excellence Award program.

21 Oct 2009

IPS examines potential for future U.N. population meeting

Inter Press Service examines the possibility of another U.N. conference on development and population within the next five years. Despite progress made since the 1994 conference on population and development (ICPD), U.N. Secretary-General Ban Ki-Moon recently noted more than 200 million women cannot access safe and effective contraception, and "too many women resort to unsafe abortions because they lack access to family planning," according to the news service.

20 Oct 2009

PCV vaccines can save the lives of millions of children

A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray defined pneumonia, was also effective against child deaths.

20 Oct 2009

Aspect Medical Systems to present a complete family of BIS monitoring technologies at ASA meeting

The American Society of Anesthesiologists (ASA) Annual Meeting will feature 62 scientific presentations that reference BIS® monitoring when it convenes on October 17-21, 2009 in New Orleans. BIS-related research will cover a broad range of applications for BIS monitoring, including initial results from studies conducted as part of a comparative effectiveness research collaboration with the Cleveland Clinic as well as findings from a study evaluating use of a Composite Variability Index (CVI) that is based on BIS parameters.

20 Oct 2009

Tempur-Pedic Hugs Back campaign to help fund research for pancreatic cancer

Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announces the Tempur-Pedic Hugs Back campaign, featuring a limited edition version of the company's popular My Tempur-Pedic Teddy Bear®.

20 Oct 2009

Humans are still evolving, says study

Although advances in medical care have improved standards of living over time, humans aren't entirely sheltered from the forces of natural selection, a new study shows.

20 Oct 2009

Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger

Seth Berkley, president and chief executive of the International AIDS Vaccine Initiative, in a New York Times opinion piece examines how the "pessimism" over the recent controversy surrounding the results of an experimental HIV vaccine tested in Thailand "may ultimately thwart other efforts to develop an AIDS vaccine.

20 Oct 2009

Article evaluating StemEx therapy for leukemia and lymphoma to be published

Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma.

19 Oct 2009

Study on the economic impact of antibiotic overuse and antibiotic-resistant infections

The Alliance for the Prudent Use of Antibiotics (APUA) and Cook County Hospital (currently John H. Stroger, Jr. Hospital of Cook County), today announced the release of an eye-opening study on the economic impact of antibiotic overuse and antibiotic-resistant infections (ARIs) sponsored by an unrestricted educational grant from bioMerieux and the Centers for Disease Control and Prevention (CDC).

19 Oct 2009

Campaign seeks to hold governments accountable to meeting MDG targets

Inter Press Service examines the Stand Up Take Action campaign, which took place October 16-18 to highlight the Millennium Development Goals' [MDG] 2015 deadline.

19 Oct 2009

Durham VA Medical Center receives Daxor's BVA-100 Blood Volume Analyzer

Daxor Corporation, a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the Institute for Medical Research at the Durham Veterans Affairs (VA) Medical Center of Durham, North Carolina.

19 Oct 2009

Amarin selects Medpace as CRO for its Phase 3 AMR101 MARINE clinical study

Amarin Corporation plc today announced that it has executed an agreement with Medpace, Inc. (‘Medpace’), a leading Contract Research Organization (CRO) with expertise in conducting clinical trials in cardiovascular and metabolic disease, to engage their services in the execution of its Phase 3 clinical trials with AMR101 in patients with very high triglyceride levels (the AMR101 MARINE Study) and mixed dyslipidemia.

19 Oct 2009

Mortality News and Research

Study shows appropriate use of CRRT improves AKI patient outcomes

AEOL 10150 increases regeneration of GI stem cells: NIAID study results

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Study explores aldosterone antagonist usage among US patients hospitalised with heart failure

Experts discuss methods to prevent catheter-associated urinary tract infections

New results from ADVANCE provide important insights to reduce diabetes complications

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

New tools needed to identify men and women at risk for the most aggressive cancers

Eclipsys' 2009 Circle of Excellence Award winners announced

IPS examines potential for future U.N. population meeting

PCV vaccines can save the lives of millions of children

Aspect Medical Systems to present a complete family of BIS monitoring technologies at ASA meeting

Tempur-Pedic Hugs Back campaign to help fund research for pancreatic cancer

Humans are still evolving, says study

Opinions: HIV vaccine; HIV resources help promote global disease control; U.S. fight against world hunger

Article evaluating StemEx therapy for leukemia and lymphoma to be published

Study on the economic impact of antibiotic overuse and antibiotic-resistant infections

Campaign seeks to hold governments accountable to meeting MDG targets

Durham VA Medical Center receives Daxor's BVA-100 Blood Volume Analyzer

Amarin selects Medpace as CRO for its Phase 3 AMR101 MARINE clinical study

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News